Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study
- PMID: 38443140
- DOI: 10.1136/ard-2023-225443
Power Doppler signal at the enthesis and bone erosions are the most discriminative OMERACT ultrasound lesions for SpA: results from the DEUS (Defining Enthesitis on Ultrasound in Spondyloarthritis) multicentre study
Abstract
Objectives: To assess, in spondyloarthritis (SpA), the discriminative value of the Outcome Measures in Rheumatology (OMERACT) ultrasound lesions of enthesitis and their associations with clinical features in this population.
Methods: In this multicentre study involving 20 rheumatology centres, clinical and ultrasound examinations of the lower limb large entheses were performed in 413 patients with SpA (axial SpA and psoriatic arthritis) and 282 disease controls (osteoarthritis and fibromyalgia). 'Active enthesitis' was defined as (1) power Doppler (PD) at the enthesis grade ≥1 plus entheseal thickening and/or hypoechoic areas, or (2) PD grade >1 (independent of the presence of entheseal thickening and/or hypoechoic areas).
Results: In the univariate analysis, all OMERACT lesions except enthesophytes/calcifications showed a significant association with SpA. PD (OR=8.77, 95% CI 4.40 to 19.20, p<0.001) and bone erosions (OR=4.75, 95% CI 2.43 to 10.10, p<0.001) retained this association in the multivariate analysis. Among the lower limb entheses, only the Achilles tendon was significantly associated with SpA (OR=1.93, 95% CI 1.30 to 2.88, p<0.001) in the multivariate analyses. Active enthesitis showed a significant association with SpA (OR=9.20, 95% CI 4.21 to 23.20, p<0.001), and unlike the individual OMERACT ultrasound lesions it was consistently associated with most clinical measures of SpA disease activity and severity in the regression analyses.
Conclusions: This large multicentre study assessed the value of different ultrasound findings of enthesitis in SpA, identifying the most discriminative ultrasound lesions and entheseal sites for SpA. Ultrasound could differentiate between SpA-related enthesitis and other forms of entheseal pathology (ie, mechanical enthesitis), thus improving the assessment of entheseal involvement in SpA.
Keywords: Arthritis, Psoriatic; Fibromyalgia; Osteoarthritis; Spondylitis, Ankylosing; Ultrasonography.
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ on behalf of EULAR.
Conflict of interest statement
Competing interests: ADM has received speaking fees from Janssen and has received support for attending meetings by Galapagos outside the submitted work. GS has received speaking fees and support for attending meetings by Novartis outside the submitted work. EC has received speaking fees from Novartis outside the submitted work. EDD has received speaking fees from Novartis and has received support for attending meetings by AbbVie outside the submitted work. MF has received speaking fees from Galapagos, AbbVie, Boehringer Ingelheim, Lilly and GSK and has received support for attending meetings by Pfizer outside the submitted work. XM has received speaking fees from AbbVie, Lilly Novartis, UCB and Janssen and has received support for attending meetings by UCB and Janssen outside the submitted work. MGR has received speaking fees from AbbVie, Raffo and Tecnofarma outside the submitted work. HM-O has received research grants from Janssen, Novartis, Pfizer and UCB and honoraria/speaker fees from AbbVie, Amgen, Eli Lilly, Janssen, Moonlake, Novartis, Pfizer, Takeda and UCB non-relevant to the submitted work. WG has received speaking fees from Accademia di Medicina, Janssen, Angelini Ethos, Galapagos, Biopharma and UVET outside the submitted work. EF has received speaking fees from AbbVie, Amgen, BMS, Janssen, Lilly, Novartis, Pfizer and Union Chimique Belge Pharma outside the submitted work.
Similar articles
-
DEUS Enthesitis Index (DEI): a new tool integrating ultrasound and clinical examination for enthesitis assessment in spondyloarthritis.RMD Open. 2025 Apr 28;11(2):e005496. doi: 10.1136/rmdopen-2025-005496. RMD Open. 2025. PMID: 40295120 Free PMC article.
-
Relationship Between Ultrasound and Physical Examination in the Assessment of Enthesitis in Patients With Spondyloarthritis: Results From the DEUS Multicenter Study.Arthritis Rheumatol. 2025 Jan;77(1):22-33. doi: 10.1002/art.42971. Epub 2024 Oct 15. Arthritis Rheumatol. 2025. PMID: 39165013
-
Reliability of a consensus-based ultrasound definition and scoring for enthesitis in spondyloarthritis and psoriatic arthritis: an OMERACT US initiative.Ann Rheum Dis. 2018 Dec;77(12):1730-1735. doi: 10.1136/annrheumdis-2018-213609. Epub 2018 Aug 3. Ann Rheum Dis. 2018. PMID: 30076154
-
Enthesitis detection by ultrasound: where are we now?Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):127-130. Epub 2018 Oct 1. Clin Exp Rheumatol. 2018. PMID: 30296977 Review.
-
Enthesitis: A hallmark of psoriatic arthritis.Semin Arthritis Rheum. 2018 Aug;48(1):35-43. doi: 10.1016/j.semarthrit.2017.12.008. Epub 2018 Jan 6. Semin Arthritis Rheum. 2018. PMID: 29429762 Review.
Cited by
-
The Challenge of IBD-Related Arthritis Screening Questionnaires in Early and Predominantly Entheseal Phenotypes.Rheumatol Ther. 2024 Oct;11(5):1321-1331. doi: 10.1007/s40744-024-00709-7. Epub 2024 Aug 17. Rheumatol Ther. 2024. PMID: 39154061 Free PMC article.
-
Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison.Rheumatol Ther. 2024 Oct;11(5):1413-1423. doi: 10.1007/s40744-024-00705-x. Epub 2024 Aug 9. Rheumatol Ther. 2024. PMID: 39120848 Free PMC article.
-
Delineating inflammatory from non-inflammatory mechanisms for therapy optimization in psoriatic arthritis.Nat Rev Rheumatol. 2025 Apr;21(4):237-248. doi: 10.1038/s41584-025-01229-6. Epub 2025 Mar 12. Nat Rev Rheumatol. 2025. PMID: 40075177 Review.
-
Entheseal Doppler signals in ultrasound are associated with vasodilator drugs and age in patients with radiographic axial spondyloarthritis.Arthritis Res Ther. 2025 Jul 14;27(1):149. doi: 10.1186/s13075-025-03614-8. Arthritis Res Ther. 2025. PMID: 40660310 Free PMC article.
-
DEUS Enthesitis Index (DEI): a new tool integrating ultrasound and clinical examination for enthesitis assessment in spondyloarthritis.RMD Open. 2025 Apr 28;11(2):e005496. doi: 10.1136/rmdopen-2025-005496. RMD Open. 2025. PMID: 40295120 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources